Ingrid Nishimoto, LCSW: Peutz-Jeghers Syndrome and Intergenerational Emotional Inheritance
Release Date: 02/12/2026
Walking the Genetic Line
Episode summary When Marisa Kimmel chose aesthetic flat closure after learning she carried a BRCA1 mutation, she wasn’t thinking about whether she would still feel like a woman. She was thinking about lowering her risk so she could stay alive for her six-month-old son. The question of femininity came later, handed to her by strangers on social media. Marisa had already done this work once. She was diagnosed with alopecia at nine, and years of trying to hold on to her hair took such a toll on her mental health that she came close to not wanting to be alive. Letting go of her hair taught her...
info_outlineWalking the Genetic Line
Episode summary Many people walk into a genetic counseling appointment expecting a blood draw. Rachel Collier wants them to know there is far more available: education, informed consent, and real space to talk through what this information could mean for their lives. Because genetic results are information you can’t unlearn, she treats testing as a true choice, including the choice not to test. Rachel describes how hereditary cancer risk tends to become real in two phases, first in the initial appointment, when memories of relatives’ cancer treatment can resurface, and again when results...
info_outlineWalking the Genetic Line
Episode summary Randi Eichenbaum was 19 when her mother died of ovarian cancer. Somewhere in those years she absorbed a quiet belief: this is going to happen to me too. Years later, a new OB-GYN recommended genetic testing based on her family history. The BRCA2 result came by phone from a third-party lab while she was at work, followed by an emailed PDF that no one walked her through. She put it in a drawer, literally and figuratively, and went back to work. What followed was a series of turning points. She became a mother and experienced acute postpartum anxiety. She had a prophylactic...
info_outlineWalking the Genetic Line
Episode summary In May 2022, at 30 years old, Jaclyn found a lump in her breast. Her doctor, seeing no family history and a young, healthy patient, suggested she wait a week and see if it was still there. Jaclyn didn't take no for an answer — she asked for a mammogram, and within a single day learned she had DCIS, an early-stage breast cancer. What came next moved at a speed she describes as "medical timeline on fast forward": genetic counseling that flagged something didn't add up in her family's supposedly cancer-free history, a large genetic panel that turned up a mutation called BRIP1,...
info_outlineWalking the Genetic Line
EPISODE SUMMARY Kathy Baker grew up in a family that, as she puts it, "looked like a poster for a BRCA mutation" — a sister diagnosed with breast cancer at 31, a mother with three primary cancers, a grandfather lost to aggressive prostate cancer, a great-grandmother lost to pancreatic cancer. And still, when genetic testing became available, Kathy said no. Not out of denial exactly, but out of a fierce instinct to protect her own life from being lived under a shadow. She was diagnosed with breast cancer herself in 2000, treated without ever seeing an oncologist first, and then spent nine...
info_outlineWalking the Genetic Line
EPISODE SUMMARY Sharsheret is the Hebrew word for chain. Not a ribbon, not a fight, not a cure — a chain. Twenty-five years in, that name turns out to be the most precise available description of the work: over 40,000 people who have shared their experience, peer matches made not by mutation status but by the specific thing you are afraid of, social workers and genetic counselors who answer the phone, pre- and post-surgery kits arriving at the house wrapped and unbilled, and more than a million dollars a year moving quietly toward the non-medical costs that make a diagnosis expensive in ways...
info_outlineWalking the Genetic Line
Episode Summary A visible tumor changed two lives at once. When Holly Taylor’s sister was diagnosed at 45 with simultaneous stage 3 ovarian and breast cancer — tumors large enough to see with the naked eye, discovered only after years of avoiding care without health insurance — genetic testing entered Holly’s life as an extension of her sister’s crisis rather than a decision of her own. An initial variant of unknown significance sat unresolved for two years before being reclassified as a pathogenic BRCA1 mutation, arriving in the middle of a four-and-a-half-year caregiving arc that...
info_outlineWalking the Genetic Line
Guest: Marleah Dean Kruzel, PhD Theme: Uncertainty as a Lifetime Companion, Not a Problem to Solve Episode Summary Marleah Dean Kruzel was 8 years old when her mother found a lump. What followed were years of surgeries, chemotherapy, radiation, and a childhood lived largely in hospitals — experiences that eventually became the foundation of a research career dedicated to understanding what previvors actually go through, and what the systems meant to support them consistently fail to provide. She tested positive for BRCA2 in 2013, after letting the test kit sit in the back of her safe for...
info_outlineWalking the Genetic Line
Guest: Natalie Samson Hart, MS, CGC, INHC Theme: Genetic Counseling as a Gateway to Whole-Person Care Episode Summary Natalie Samson Hart didn’t come to oncology genetic counseling through a tidy career trajectory. She came through loss, confusion, and proximity to illness — a brother whose neurodivergence led her toward the intersection of science and human connection, a father diagnosed with stage 4 cancer while she was still in graduate school and rotating through cancer wards. That collision of the personal and professional is what eventually pushed her out of traditional...
info_outlineWalking the Genetic Line
Guest: Krista (Oncology Nurse Navigator) Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood EPISODE SUMMARY When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying...
info_outlineGuest: Ingrid Nishimoto, LCSW
Theme: Inherited Narratives—Moving Beyond the Parent’s Story to Claim Your Own
Episode Summary
When Ingrid Nishimoto was diagnosed with Peutz-Jeghers Syndrome at age 17, she wasn't just handed a medical management plan; she was handed a mirror of her father’s life and early death. In this profound conversation with Sara Champie, LCSW, Ingrid explores the "Time Collapse" that occurs when a genetic diagnosis makes the past and future converge in the present. As a fellow psychotherapist, Ingrid deconstructs the emotional burden of living past the age a parent died, the adaptive nature of hyper-vigilance, and the radical act of choosing her own path in a medical system that often prioritizes physical data over the human soul.
We Cover
-
The Origin Story: Discovering Peutz-Jeghers Syndrome at 17 after years of "nameless" abdominal pain and the visible markers of pigmentation—and the immediate shift from high-school senior to a high-risk patient.
-
Intergenerational Inheritance: Navigating the grief and anger of "replacing" a parent’s narrative, specifically the complexity of living past the age of 37—the year Ingrid’s father passed away from the same condition.
-
The "Responsibility Reflex" in Healthcare: How high-achievers often try to "figure it all out" or over-function as a survival strategy when faced with medical uncertainty.
-
Medical vs. Emotional Care: The gap in the Western medical system where physical scans are prioritized, but the mental health impact of "waiting for results" is often left unaddressed.
-
Relationship to Risk: A deep dive into "Risk-Neutral Spaces"—learning that there is no right or wrong way to feel about screening, and how Ingrid moved from rigid self-protection to a more expansive relationship with her body.
-
The Burden of Choice: Deciding between the stability of an employer-based health system and the agency of private practice while carrying a "pre-existing" genetic reality.
Highlights & Takeaways
-
"My Story is Unique": A genetic mutation may be inherited, but the narrative you build around it is yours to claim. You are not doomed to repeat the past.
-
The Body as Information: Physical symptoms, like hyper-vigilance or "racing heart" during scans, are not flaws; they are the nervous system’s attempt to keep you safe.
-
Permission for Ambivalence: It is possible to be grateful for medical technology while simultaneously feeling anger or protest toward the burden it places on your life.
-
Slowing Down the Reaction: Meaningful decision-making requires emotional safety and the permission to "not know" the future while staying grounded in the present.
Content Note
This episode discusses hereditary cancer syndromes, the loss of a parent, medical trauma, surgical anxiety, and the emotional complexities of long-term monitoring.
Resources Mentioned
-
Ingrid Nishimoto, LCSW: Connect with Ingrid and her private practice work at ingridnishimototherapy.com.
-
The Responsibility Reflex Quiz: Take the quiz to discover your survival strategies under medical stress at sarachampielcsw.com.
-
Face the Risk Together: Sara Champie’s 10-week psychotherapy group for women and gender-diverse people in California.
-
Peutz-Jeghers Syndrome (PJS) Information: NORD (National Organization for Rare Disorders) .
Connect
If this conversation resonates, please follow, rate, and share. Help us reach the high-achieving "over-functioners" who need to know they don't have to carry the risk alone. Instagram: @FaceTheRiskTogether Web: www.sarachampielcsw.com